|
News: T-Cell Therapy for ALL Shows Benefit
|
Researchers reported encouraging but preliminary results of gene-based immune therapy in two children with relapsed and refractory acute lymphoblastic leukemia (ALL). Both children achieved a remission after they were given T cells modified to attack B cells bearing the surface protein CD19, according to Stephan A. Grupp, MD, PhD, of the Children's Hospital of Philadelphia, and colleagues.
Read more... |
|
Conferences
|
| - |
12 April 2013, Gene Therapy: Charting a Future Course - NIH/OBA meeting, Bethesda, MD |
| - |
17 - 19 April 2013, Annual conference of the British Society for Gene Therapy (BSGT), London, UK |
| - |
22 April 2013, 8th Annual Conference of The Israeli Society of Gene Therapy (ISGCT), Jerusalem, Israel |
| - |
22 - 25 April 2013, International Society for Cellular Therapy (ISCT) 19th Annual Meeting, Auckland, New Zealand |
| - |
5 - 10 May 2013, Gordon Research Conference: Virusses & Cells, Lucca (Barga), Italy |
| - |
8 – 10 May 2013, 8th Australasian Gene Therapy Society Meeting (AGTS), Sydney, Australia |
| - |
15 – 18 May 2013, American Society of Gene and Cell Therapy (ASGCT) 16th Annual Meeting, Salt Lake City, Utah |
| - |
4 – 6 July 2013, The 19th Annual Meeting of the Japan Society of Gene Therapy (JSGT), Okayama, Japan |
| - |
12 – 14 August 2013, International Conference on Genetic Engineering & Genetically Modified Organisms, Raleigh, North Carolina |
| - |
23 – 25 October 2013, 2nd International Conference and Exhibition on Cell & Gene Therapy, Orlanda, Florida |
| - |
24 – 28 October 2013, VII Congress of the Spanish Society of Gene (SETGyC) and Cell Therapy, and XXI Congress of the European Society of Gene and Cell Therapy (ESGCT), Madrid, Spain |
| - |
20 – 22 November 2013, 12th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases, Sonoma, California |
Read more... |
|
|
